{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:06:30Z","timestamp":1782108390650,"version":"3.54.5"},"reference-count":68,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1002\/hon.3146","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T21:16:34Z","timestamp":1686345394000},"page":"136-143","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Approach to relapsed CLL including Richter Transformation"],"prefix":"10.1002","volume":"41","author":[{"given":"John F.","family":"Seymour","sequence":"first","affiliation":[{"name":"Peter MacCallum Cancer Centre Royal Melbourne Hospital University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.01028"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_279099"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-873083"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200012283432602"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.120238"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-546150"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-488197"},{"key":"e_1_2_9_10_1","first-page":"436","article-title":"Mechanisms of resistance to BTK inhibitors in patients with chronic lymphocytic leukemia","volume":"19","author":"Woyach JA","year":"2021","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-18-1119"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004205"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature15395"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/radiation1010006"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2133538"},{"key":"e_1_2_9_16_1","first-page":"571","article-title":"Skin cancer in patients with chronic lymphocytic leukemia and non\u2010Hodgkin lymphoma","volume":"10","author":"Onajin O","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000707"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.265777"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00224-5"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2114110"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008325"},{"key":"e_1_2_9_22_1","author":"Mato AR","journal-title":"N Engl J Med"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004782"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30909-9"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021015014"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014488"},{"issue":"3","key":"e_1_2_9_27_1","article-title":"Absence of BTK, BCL2, and PLCG2 mutations in relapsing chronic lymphocytic leukemia (CLL) after first\u2010line treatment with fixed\u2010duration ibrutinib (I) plus venetoclax (V)","volume":"6","author":"Croner LJ","year":"2022","journal-title":"HemaSphere"},{"issue":"2","key":"e_1_2_9_28_1","first-page":"265","article-title":"Impact of unfavorable genetics on minimal residual disease (MRD) response to venetoclax + rituximab retreatment in relapsed or refractory chronic lymphocytic leukemia (R\/R CLL): MURANO phase 3 substudy","volume":"5","author":"Wu JQ","year":"2021","journal-title":"HemaSphere"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v94.6.1848.418k05_1848_1854"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v94.6.1840"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.00948"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01181"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25638"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.5795"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.207068"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.01460"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.03355"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000801"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01210"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2211582"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008201"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(19)30085-7"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1022770"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001205"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001204"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010536"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.251488"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.056"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157060"},{"issue":"3","key":"e_1_2_9_50_1","article-title":"Ibrutinib for treatment of relapsed\u2010refractory chronic lymphocytic leukemia: a matching\u2010adjusted indirect comparison of 3 randomized phase 3 trials","volume":"7","author":"Ghia P","year":"2023","journal-title":"HemaSphere"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.272500"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(22)00320-9"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1513257"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)30019-5"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.76.6840"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018882555"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30012-8"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009578"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007812"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1713976"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.01580"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008502"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005083"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-21-1237"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/ppo.0000000000000532"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005650"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001077"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011386"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157058"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.3146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:32:15Z","timestamp":1692426735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.3146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":68,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1002\/hon.3146"],"URL":"https:\/\/doi.org\/10.1002\/hon.3146","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2023-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}